Structure Therapeutics (GPCR) Other Accumulated Expenses (2022 - 2026)

Structure Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $8.3 million for Q1 2026.

• In Q1 2026, Other Accumulated Expenses rose 221.24% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (up 221.24% YoY), while the FY2025 annual figure was $12.4 million, up 127.18% from the prior year.
• Other Accumulated Expenses was $8.3 million for Q1 2026 at Structure Therapeutics, down from $12.4 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $12.4 million in Q4 2025 to a low of $454000.0 in Q4 2022.
• Historically, Other Accumulated Expenses has averaged $3.7 million across 5 years, with a median of $2.9 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses jumped 399.24% in 2024, then plunged 60.96% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $454000.0 in 2022, then surged by 223.57% to $1.5 million in 2023, then jumped by 271.68% to $5.5 million in 2024, then jumped by 127.18% to $12.4 million in 2025, then slumped by 32.69% to $8.3 million in 2026.
• The last three Other Accumulated Expenses figures came in at $8.3 million (Q1 2026), $12.4 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.